Drug Shortage Report for DILANTIN-125 SUSPENSION

Last updated on 2024-06-11 History
Report ID 230126
Drug Identification Number 00023450
Brand name DILANTIN-125 SUSPENSION
Common or Proper name PHENYTOIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) PHENYTOIN
Strength(s) 125MG
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size 250ML
ATC code N03AB
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-06-03
Estimated end date 2024-12-10
Actual end date
Shortage status Actual shortage
Updated date 2024-06-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-06-11 French Compare
v1 2024-06-11 English Compare

Showing 1 to 2 of 2